Browse by category

AstraZeneca enters obesity market with $2b deal for GLP-1 candidate

AstraZeneca has signed an exclusive license agreement with Shanghai-based biotech Eccogene for ECC5004, an early-stage investigational...

BMS may help reduce heart failure-related risk factors

7 hours ago

GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour

1 day ago

Bariatric surgery induces changes in taste perception, desire and enjoyment of flavours

1 day ago

Weekly Digest